萬辰生物(300972.SZ)IPO擬發行3837.5萬股 4月1日定價、6日申購
格隆匯3月26日丨萬辰生物(300972.SZ)首次公開發行股票並在創業板上市初步詢價及推介公吿,此次公開發行股份3837.50萬股,佔發行後公司總股本的25.00%,發行後公司總股本為1.5350億股;全部為公開發行新股,不安排老股轉讓。
其中,初始戰略配售發行數量為191.8750萬股,佔此次發行數量的5.00%。回撥機制啟動前,網下初始發行數量為2551.9750萬股,約佔扣除初始戰略配售數量後發行數量的70.00%,網上初始發行數量為1093.65萬股,約佔扣除初始戰略配售數量後發行數量的30.00%。
初步詢價時間為2021年3月31日,4月1日確定發行價格,4月2日網上路演,4月6日網上申購配號,4月12日刊登《發行結果公吿》。公吿顯示,公司網上、網下發行申購日為4月6日,4月8日將公佈中籤結果。
發行人股票簡稱為“萬辰生物”,股票代碼為“300972”,該代碼同時用於此次發行的初步詢價、網下申購及網上申購。根據《上市公司行業分類指引》(2012年修訂),發行人所屬行業為“農業”(A01)”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.